Otte, C., Jahn, H., Yassouridis, A., Arlt, J., Stober, N., Maass, P., et al. (2003). The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Life Sciences, 73(14), 1835-1845.